Liposomes, versatile carriers for targeted delivery of therapeutics, continue to demonstrate potential in biomedical applications. A unique mode of administration, known as foot pad administration, allows for an innovative approach, particularly when administering to laboratory animals such as mice or rats.
The foot pad administration of liposomes, specifically in rodents, involves the direct injection of liposomes into the plantar surface of the hind foot. Foot pad administration takes advantage of the unique physiology of the foot pad area. The foot pads are thick, hairless, and have a thinner skin layer compared to other body parts. This allows for a high degree of absorption and uptake of administered substances.
When it comes to foot pad administration of liposomes, the liposomes, being nanocarriers, are expertly designed to encapsulate therapeutic drugs or other molecules. Once applied on the foot, they traverse through the skin layers reaching the blood vessels in the dermis layer. From there, they enter the systemic circulation, ensuring a uniform distribution of the encapsulated drug throughout the body.
Several varieties of liposomes are used in foot pad administration, each designed for specific purposes. Among these, the most frequently adopted types are conventional liposomes that encapsulate water-soluble drugs, and liposomes that can encapsulate oily or lipophilic substances in their lipid bilayers. These liposomes can be modified to adjust their size, charge, and lipid composition to enhance the encapsulation efficiency and absorption of liposomes in the foot pad. PEGylated liposomes, for instance, offer an improved circulatory lifespan, while cationic liposomes enhance cellular uptake. The choice of liposome largely depends on the nature of the drug or molecule to be delivered and its intended therapeutic application.
Foot pad administration of liposomes is known for its use in immunology and research into the immune response. It has been instrumental in studies investigating lymphocyte migration from skin to lymph nodes by utilizing liposome-encapsulated fluorescence markers. Once administered into the footpads of rodents, the particles can be tracked by following the fluorescence. Furthermore, this method has been utilized for evaluating the effectiveness of various drugs on local inflammation. In such applications, liposomes encapsulating anti-inflammatory drugs are injected into the footpad, and the reduction in swelling gives an indication of the drug's effectiveness. Another application is in the field of vaccination, particularly in administering antigens for triggering robust systemic immune responses.
Foot pad administration of liposomes has several merits. First and foremost, the unique anatomical structure of the rodent's foot pad allows for the slow absorption of the liposomes, ensuring a sustained and controlled release of the encapsulated drug. The non-invasive nature of this delivery method ensures minimal discomfort to the animal, a vital aspect concerning ethical use of animals in research. The safety of liposomes as carriers is an added advantage. Given their biodegradability and biocompatibility, liposomes deliver the drug payload without inducing toxic responses. Lastly, foot pad administration also facilitates investigation of lymphatic migration patterns, proving an advantageous tool in immunological studies.
Foot pad administration of liposomes provides a unique method for a safe and controlled delivery of therapeutics. As research continues to evolve, more sophisticated novel applications of the foot pad administration of liposomes are expected to emerge.
Creative Biolabs is proud to offer our clients a series of liposome services and products. Please contact us for more information.
For Research Use Only. Not For Clinical UseSupports
Online Inquiry
Creative Biolabs is a world-leading liposome provider with extensive experience in liposome preparation, custom formulation development, and characterization.
© 2026 Creative Biolabs. All rights reserved.